1. Managing female urinary incontinence: a regional prospective analysis of cost-utility ratios (curs) and effectiveness.
- Author
-
Costantini E, Lazzeri M, Bini V, Zucchi A, Scarponi E, and Porena M
- Subjects
- Adult, Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Humans, Middle Aged, Prospective Studies, Urinary Incontinence diagnosis, Urinary Incontinence economics, Urinary Incontinence therapy
- Abstract
Introduction: To evaluate the cost-utility of incontinence treatments, particularly anticholinergic therapy, by examining costs and quality-adjusted life years., Materials and Methods: A prospective cohort study of women who were consecutively referred by general practitioners (GPs) to the Urology Department because of urinary incontinence. The primary outcome was evaluation of the cost-utility of incontinence treatments (surgery, medical therapy and physiotherapy) for stress and/or urgency incontinence by examining costs and quality-adjusted life years., Results: 137 consecutive female patients (mean age 60.6 ± 11.6; range 36-81) were enrolled and stratified according to pathologies: SUI and UUI. Group A: SUI grade II-III: 43 patients who underwent mid-urethral sling (MUS); Group B: SUI grade I-II 57 patients who underwent pelvic floor muscle exercise and Group C: UUI: 37 patients who underwent antimuscarinic treatment with 5 mg solifenacin daily. The cost utility ratio (CUR) was estimated as saving more than €1200 per QALY for surgery and physiotherapy and as costing under € 100 per QALY for drug therapy., Conclusions: This study shows that appropriate diagnosis and treatment of a patient with incontinence lowers National Health Service costs and improves the benefits of treatment and quality of life.
- Published
- 2014
- Full Text
- View/download PDF